Vitamin K2: The Bone-and-Artery Vitamin, Explained

At a Tokyo breakfast table, a bowl of natto — sticky, pungent, fermented soybeans — gets stirred into rice without ceremony. Most Western visitors push it politely aside. Nutrition researchers, meanwhile, have spent two decades studying it, because natto happens to be the single richest food source of a nutrient most of us have never tracked: vitamin K2.

Walk any supplement aisle now and K2 is having a moment, usually paired with vitamin D3 and sold with confident promises about “strong bones and clean arteries.” The confidence outpaces the science, but not by as much as skeptics assume. The mechanism behind K2 is genuinely elegant, and the human data — while incomplete — is intriguing enough that researchers keep funding trials.

So here is the honest version: what K2 actually does in the body, where the evidence is solid, where it thins out, and how to get it from a plate instead of a pill.

What is vitamin K2 — and how is it different from K1?

Vitamin K got its name from the German word Koagulation, because the Danish scientist who discovered it in the 1930s was studying blood clotting. What he found turned out to be a family of related compounds, not a single vitamin.

Vitamin K1, called phylloquinone, lives in green plants — spinach, kale, broccoli, collards. It supplies the vast majority of vitamin K in Western diets, and the liver uses it primarily to build clotting proteins. Vitamin K2, the menaquinones, comes from bacteria and animal tissues instead. The menaquinones form a series, labeled MK-4 through MK-13 depending on the length of their chemical side chain, and that structural difference matters more than it sounds: it changes how long each form circulates and which tissues it reaches.

Here is the useful simplification, supported by tracer studies: K1 tends to be captured quickly by the liver for clotting duty, while K2 — especially the longer-chain forms — stays in the bloodstream longer and reaches tissues beyond the liver, including bone and blood vessel walls. That distribution pattern is why researchers suspect K2, rather than K1, does most of the work on the skeleton and the arteries. Both forms count toward your total vitamin K intake, but they are not interchangeable in where they end up.

How vitamin K2 works: the body's calcium traffic cop

Every form of vitamin K does one core job. It serves as a cofactor for an enzyme that “switches on” certain proteins through a chemical step called carboxylation. Without enough vitamin K, those proteins are built but left inactive — like keys cut without teeth.

Two of those proteins explain nearly all the excitement around K2. The first is osteocalcin, made by bone-building cells. Once activated by vitamin K, osteocalcin can bind calcium and help anchor it into the bone matrix. The second is matrix Gla protein, or MGP, produced in blood vessel walls and cartilage. Activated MGP is one of the most powerful known inhibitors of soft-tissue calcification — it actively discourages calcium from depositing where it doesn’t belong, including artery walls.

Researchers can measure how well this system is running. When vitamin K is scarce, the inactive versions of these proteins — undercarboxylated osteocalcin and dephospho-uncarboxylated MGP — rise in the blood. Studies consistently show that many otherwise healthy adults carry measurable levels of these inactive proteins, and that K2 intake lowers them within weeks. In other words, the biochemical machinery clearly responds to K2. The harder question, which the next two sections tackle, is whether flipping those molecular switches translates into fewer fractures and healthier arteries over years.

Does vitamin K2 really help your bones?

The bone story starts in Japan, where a menaquinone form of vitamin K has been used in osteoporosis care for decades. Early Japanese trials reported impressive reductions in fractures — but many were small, and later reviews flagged quality problems, so those numbers are best read cautiously.

The most rigorous modern evidence comes from a three-year Dutch trial published in 2013, which followed 244 healthy postmenopausal women taking the MK-7 form of K2. Compared with placebo, the K2 group lost significantly less bone mineral density at the lumbar spine and femoral neck, and bone strength indices held up better. Encouraging — but note what the trial measured: bone density, not fractures. A slower decline on a scan does not automatically mean fewer broken bones, and no large trial outside Japan has yet proven fracture prevention with K2.

Meta-analyses land in the middle. Vitamin K supplementation appears to modestly improve markers of bone quality, particularly in postmenopausal women, while fracture data remain inconsistent. What is well established is the flip side: chronically low vitamin K status is associated with lower bone density and higher fracture risk in observational studies.

My read of the evidence: K2 is a reasonable supporting actor for bone health — behind the proven leads of adequate calcium, vitamin D, protein, and weight-bearing exercise — not a headliner.

Can vitamin K2 keep calcium out of your arteries?

This is K2’s boldest claim, and the honest answer has two halves.

The observational half is striking. In the Rotterdam Study, which tracked nearly 4,800 Dutch adults for seven to ten years, people with the highest dietary K2 intake had roughly half the risk of dying from coronary heart disease compared with those consuming the least, along with less severe aortic calcification. Vitamin K1 intake showed no such association. Other population studies have pointed the same direction. But observational research can only show associations — people who eat more K2-rich foods may differ in dozens of other ways.

The trial half is more sobering. A three-year study in healthy postmenopausal women found that MK-7 supplementation reduced markers of arterial stiffness, particularly in women whose arteries were stiffer to begin with. Yet trials that tried to slow existing coronary artery calcification — including studies in people with kidney disease, who calcify rapidly — have mostly come up short. No trial has yet shown that K2 prevents heart attacks or strokes, and several are still underway.

The fair summary: the mechanism is real, the population data is consistent, and the definitive trials haven’t delivered a verdict. Anyone selling K2 as artery insurance is ahead of the evidence. Anyone dismissing it entirely is behind it.

What happens if I take vitamin K2 every day?

Less than the marketing implies, and nothing you would feel. Vitamin K2 is not a stimulant, a painkiller, or a mood-lifter — there is no noticeable effect to wait for, which is worth knowing before you conclude a supplement “isn’t working.”

Biochemically, daily K2 does produce measurable changes. Within a few weeks, blood levels of the inactive forms of osteocalcin and matrix Gla protein fall, meaning more of those calcium-handling proteins are switched on. With the long-acting MK-7 form, blood levels build steadily over the first weeks and then plateau. Any downstream effects on bone density or vessel stiffness, where they occur at all, take years to show up on a scan — the key trials ran for three years.

A few practical points for daily users:

• K2 is fat-soluble, so it absorbs best with a meal that contains some fat — eggs, yogurt, olive oil, nuts.
• Consistency matters more than timing; the goal is a stable vitamin K status, which is also why people on certain blood thinners must keep intake steady or avoid changes entirely (more on that below).
• Unlike vitamins A and D, K2 is metabolized and cleared relatively quickly, and no toxicity from high dietary or supplemental intake has been reported in healthy people.

Daily K2 from food — a serving of natto, a wedge of aged Gouda — accomplishes the same biochemistry, with better company on the plate.

Should you take D3 and K2 together?

The pairing sounds almost too tidy: vitamin D increases how much calcium your gut absorbs, and vitamin K2 activates the proteins that decide where that calcium goes. Supplement labels present them as inseparable partners. What does the evidence actually show?

The mechanism is genuinely complementary — that part isn’t hype. Vitamin D also increases the body’s production of osteocalcin and matrix Gla protein, the very proteins K2 must activate, so the two nutrients work on the same assembly line. A handful of small trials, mostly in postmenopausal women, found that combining vitamin K with vitamin D and calcium improved bone density slightly more than vitamin D and calcium alone.

What the evidence does not show is the scarier claim circulating online: that taking vitamin D without K2 is dangerous and will calcify your arteries. At ordinary intakes, there is no good human evidence for that. The theory borrows from animal studies using enormous vitamin D amounts — not a realistic model of someone taking a standard supplement.

A sensible bottom line: if you already take vitamin D and eat few K2-rich foods, adding K2 is a low-risk, plausibly useful move, and combination products are convenient. But you are optimizing, not averting a hazard. Neither nutrient rescues a diet short on calcium, protein, and produce — and vitamin D status is something worth confirming with your clinician rather than guessing at.

What are the side effects of taking vitamin K2?

For most healthy people, remarkably few. In clinical trials lasting up to three years, K2 supplementation was well tolerated, with side-effect rates similar to placebo. Occasional mild stomach upset gets reported, as with almost any supplement. Notably, U.S. authorities have never set a tolerable upper intake level for vitamin K — not because unlimited amounts are wise, but because toxicity has not been observed at the intakes studied. That absence of a ceiling reflects an absence of documented harm, not a green light for megadosing.

One exception towers over everything else. If you take a vitamin K antagonist — a class of blood-thinning medication that works precisely by blocking vitamin K — then K2 directly counteracts your treatment. Even modest, inconsistent amounts can swing your clotting measurements out of range, which is genuinely risky. People on these medicines should never start, stop, or change vitamin K intake, from supplements or big dietary shifts, without their prescriber’s guidance. Newer classes of blood thinners work differently and don’t interact with vitamin K the same way, but that determination belongs to your clinician, not a label.

Two smaller cautions: people with advanced kidney disease handle mineral balance differently and should involve their care team before any supplement, and anyone scheduled for surgery should disclose every supplement they take, K2 included. Supplements also aren’t verified for potency the way medications are, so third-party-tested products are the safer choice.

How to get K2 naturally: the best food sources

K2 comes from two places: bacteria, which produce it during fermentation, and animal tissues, which convert dietary K1 into the MK-4 form. That’s why the K2 champions are fermented foods and certain animal products — and why strict low-fat, low-fermented diets tend to run lean on it. In typical Western diets, K2 supplies only about 10 to 25 percent of total vitamin K intake.

Nothing else comes close to natto. The specific bacterium used to ferment it churns out long-chain MK-7 in quantities no other common food approaches — a single traditional serving delivers more K2 than most people eat in a week. For those who can’t embrace natto’s texture, cheese is the realistic Western workhorse: the bacteria in aged and fermented cheeses produce meaningful MK-8 and MK-9.

Food	Main K2 form	Approximate K2 per 100 g
Natto (fermented soybeans)	MK-7	850–1,000 mcg
Hard cheeses (Gouda, Edam, aged types)	MK-8, MK-9	40–80 mcg
Soft ripened cheeses (Brie style)	MK-8, MK-9	30–60 mcg
Egg yolk	MK-4	15–30 mcg
Chicken (especially dark meat)	MK-4	10–35 mcg
Butter	MK-4	~15 mcg
Sauerkraut	Mixed menaquinones	~5 mcg

Amounts vary with production methods and animal feed, so treat these as ranges, not lab certificates. Pair any of them with a little dietary fat — usually automatic, given the list — and absorption takes care of itself.

MK-4 vs. MK-7: does the type of K2 matter?

Flip over two K2 supplement bottles and you may find different molecules inside. The distinction is more than marketing.

MK-4 is the short-chain form found in animal foods — egg yolks, dark chicken meat, butter — and the form your own tissues can make by converting vitamin K1. Its weakness is speed: MK-4 clears from the bloodstream within hours, so keeping levels steady from a supplement requires repeated intake through the day. Most of the older Japanese bone research used MK-4.

MK-7 is the long-chain form produced by bacterial fermentation, the one that makes natto famous. Its side chain lets it hitch a ride on circulating lipoproteins, giving it a half-life of roughly three days — compared with an hour or two for K1 and MK-4. Head-to-head absorption studies show that MK-7 produces higher, far more stable blood levels than the same amount of MK-4, and reaches tissues beyond the liver more efficiently. Nearly all the modern European trials — the three-year bone study, the arterial stiffness study — used MK-7 for exactly this reason.

Does that make MK-7 “better”? For maintaining steady vitamin K status with once-daily intake, the pharmacology clearly favors it, and it’s the form with the strongest recent trial record. But no rigorous study has pitted the two forms against each other on outcomes that matter, like fractures. If you get K2 from food, you’ll naturally get a mix — which is its own kind of answer.

Can your gut bacteria make vitamin K2 for you?

They can make it. Whether you can use much of it is another matter.

Bacteria living in the large intestine synthesize substantial quantities of long-chain menaquinones — MK-10, MK-11, and beyond. For years this fueled a reassuring assumption: even if your diet skimps on vitamin K, your microbiome has you covered. The reality is less generous. Vitamin K is fat-soluble, and absorbing fat-soluble compounds requires bile salts, which are largely reabsorbed before food residue ever reaches the colon. The menaquinones your gut bacteria produce are made in precisely the segment of the intestine least equipped to absorb them. Some absorption likely occurs — long-chain menaquinones do show up in human liver tissue — but researchers consider the contribution to overall vitamin K status modest and hard to quantify.

Two practical implications follow. First, you cannot outsource your K2 intake to your microbiome; food still has to do the heavy lifting. Second, this pathway helps explain why prolonged courses of broad-spectrum antibiotics can nudge vitamin K status downward, particularly in people who are already eating poorly — hospitalized patients, for instance. The bacterial supply line, whatever it contributes, gets disrupted.

There’s a pleasing symmetry here: the same fermentation chemistry happening in cheese vats and natto trays is happening inside you. The difference is that when bacteria do the work outside your body first, you actually absorb the product.

Who is most likely to run low on vitamin K2?

Outright vitamin K deficiency — the kind that causes bleeding problems — is rare in healthy adults, because clotting gets first claim on whatever vitamin K is available. The more common and quieter scenario is what researchers call subclinical insufficiency: enough K for the liver’s clotting factors, but not enough left over to fully activate the bone and vessel proteins. Studies measuring inactive matrix Gla protein suggest this state is widespread, and it becomes more common with age.

Some people are more likely to land there than others:

• Anyone whose diet skips the K2 foods. No fermented foods, little cheese, few egg yolks — a pattern common in strictly low-fat diets and in some plant-based diets that don’t include natto or fermented vegetables.
• People with fat malabsorption. Celiac disease, Crohn’s disease, cystic fibrosis, chronic pancreatitis, liver or gallbladder disease, and a history of bariatric surgery all impair absorption of fat-soluble vitamins, K included.
• People on long courses of broad-spectrum antibiotics, which suppress the gut bacteria that contribute menaquinones.
• Older adults, who tend to eat less overall and absorb fat-soluble nutrients less efficiently.

One frustrating gap: there is no routine blood test for K2 status. The research markers — undercarboxylated osteocalcin, dephospho-uncarboxylated MGP — aren’t part of standard lab panels. For now, the practical assessment is simply an honest look at your plate.

Does K2 do anything for teeth, brain, or blood sugar?

Once a nutrient trends, claims multiply faster than trials. Here’s where the fringes of K2 research actually stand.

Teeth. The logic is plausible: dentin, the tissue beneath enamel, contains osteocalcin, the same K2-dependent protein found in bone. But plausibility is all there is. No clinical trial has tested whether K2 prevents cavities or strengthens teeth in humans. The claim runs almost entirely on mechanism and enthusiasm.

Brain. Vitamin K participates in building sphingolipids, fat molecules abundant in brain cell membranes, and some observational studies link better vitamin K status with better cognitive performance in older adults. Observational is the operative word — no trial has shown K2 protects memory or prevents dementia.

Blood sugar. This one is genuinely interesting. Osteocalcin, once activated, appears to act as a hormone influencing insulin sensitivity, and a few small studies associate higher K2 intake with lower diabetes risk. The studies are small and short; consider it a hypothesis worth watching, not a reason to supplement.

Cancer. One large European cohort found an association between higher K2 intake and lower cancer mortality. It remains a single observational finding, unconfirmed by trials, and should be treated accordingly.

The pattern across all four: real biology, thin human evidence. That’s not a dismissal — it’s the normal early stage of nutrition science. But it means these benefits belong in the “possible” column, and honest health writing keeps them there.

How much vitamin K do you actually need?

Here’s a fact that surprises most supplement shoppers: there is no official recommended intake for vitamin K2 specifically. U.S. guidelines set an adequate intake for total vitamin K — all forms combined — at 120 micrograms a day for adult men and 90 micrograms for adult women. Those figures were calibrated around what’s needed for normal blood clotting, using typical intakes of mostly K1 from vegetables, because that’s where the strongest data existed when the numbers were set.

Whether the amounts that fully activate osteocalcin and matrix Gla protein are higher than the amounts that ensure normal clotting is one of the livelier open questions in vitamin K research. Biomarker studies suggest that many adults who comfortably meet the clotting threshold still carry inactive bone and vessel proteins — a hint, though not proof, that “enough to clot” and “enough for everything else” may be two different numbers. Regulators haven’t moved yet, and until outcome trials clarify the picture, they probably won’t.

What does a food-first day of solid vitamin K status look like? A cup of cooked leafy greens covers the K1 requirement several times over. Layer in one or two K2 sources — a slice of aged cheese at lunch, an egg at breakfast, dark-meat chicken at dinner, natto if you’re adventurous — and you’ve supplied both branches of the family without opening a single bottle. For most people eating varied diets, that’s the whole assignment.

When to talk to a doctor before taking vitamin K2

K2 sits near the safe end of the supplement spectrum, but a few situations move the conversation from the supplement aisle to a clinician’s office — and one of them is non-negotiable.

• You take any blood-thinning medication. If your medicine belongs to the vitamin K antagonist class, K2 works directly against it, and even small changes in intake can destabilize your clotting numbers. Do not start K2, and don’t dramatically change your diet’s vitamin K content, without your prescriber’s sign-off. If you’re unsure which class your blood thinner belongs to, that alone is the question to ask.
• You have kidney disease. Mineral and calcium handling changes with reduced kidney function, and supplement decisions belong with your nephrology team.
• You’re pregnant or breastfeeding. Vitamin K from food is essential during pregnancy, but supplement amounts beyond a prenatal vitamin haven’t been well studied — check first.
• You have surgery scheduled. Surgeons need a complete supplement list because anything affecting clotting pathways matters in the operating room.

Separately, know the warning signs that suggest a genuine vitamin K problem or a clotting issue: easy or unexplained bruising, bleeding gums, nosebleeds that won’t stop, blood in urine or stool, or unusually heavy menstrual bleeding. None of these call for a supplement — they call for a prompt medical appointment, because they can signal conditions well beyond nutrition.

For everyone else, the calculus is simple: food sources are safe for essentially all healthy people, and if you choose a supplement, a third-party-tested product and a mention at your next checkup cover the bases.

Frequently asked questions

What happens if I take vitamin K2 every day?

Nothing you’ll feel — K2 has no noticeable immediate effect. Biochemically, daily intake activates more of the calcium-handling proteins osteocalcin and matrix Gla protein within a few weeks, which is measurable in blood tests used in research. Any effects on bone density or arterial stiffness, where they occur, take years; key trials ran three years. Take it with a meal containing fat, and avoid it entirely without medical advice if you use vitamin-K-blocking blood thinners.

Should you take D3 and K2 together?

It’s reasonable but not proven necessary. Vitamin D increases calcium absorption and boosts production of the proteins K2 activates, so the mechanisms are complementary, and a few small trials found modestly better bone results with the combination. However, there’s no good human evidence that taking vitamin D alone at ordinary amounts calcifies arteries — that claim comes from extreme animal studies. If you take D3 and eat few K2-rich foods, pairing them is a sensible, low-risk choice.

What is the side effect of taking vitamin K2?

In trials lasting up to three years, side effects were similar to placebo, with occasional mild stomach upset the most common complaint. No toxicity from high intakes has been documented, and no upper limit has been set. The serious exception is drug interaction: K2 directly counteracts vitamin K antagonist blood thinners and can destabilize clotting control. People on those medications, and those with kidney disease or upcoming surgery, should consult a clinician first.

How do I get K2 naturally from food?

Natto is by far the richest source, delivering roughly 850 to 1,000 micrograms per 100 grams. More approachable options include aged hard cheeses like Gouda and Edam (about 40 to 80 micrograms per 100 grams), soft ripened cheeses, egg yolks, dark-meat chicken, butter, and fermented vegetables like sauerkraut. Because K2 is fat-soluble, these foods conveniently supply their own absorption vehicle. A daily serving or two of fermented or animal-based K2 foods covers most people.

Is vitamin K2 the same as vitamin K1?

No. Both belong to the vitamin K family and support blood clotting, but they differ in source and destination. K1 (phylloquinone) comes from leafy greens and is used mainly by the liver for clotting proteins. K2 (the menaquinones) comes from bacterial fermentation and animal foods, stays in circulation longer — especially the MK-7 form — and reaches bone and blood vessel tissue more readily. They count toward the same total vitamin K intake but aren’t interchangeable.

Can vitamin K2 reverse calcification that's already in my arteries?

Current evidence says no. Trials testing whether K2 could slow or reverse existing coronary artery calcification — including studies in people with kidney disease who calcify quickly — have mostly not shown benefit. The stronger data concern prevention and vessel flexibility: one three-year trial found MK-7 reduced arterial stiffness markers in postmenopausal women. Established calcification appears very difficult to undo with any nutrient, so K2’s realistic role, if confirmed, is protective rather than restorative.

How long does it take for vitamin K2 to work?

Blood markers respond within weeks — levels of inactive osteocalcin and matrix Gla protein fall as K2 activates those proteins. Structural changes take far longer. The trial showing slower bone density loss in postmenopausal women ran three years, as did the study showing reduced arterial stiffness. There is no short-term effect you can feel, so judge K2 by long-term habits and overall diet quality, not by how you feel after a month.

Does vitamin K2 interact with medications?

The critical interaction is with vitamin K antagonist blood thinners, which work by blocking vitamin K; K2 directly opposes them and can push clotting measurements out of the safe range. Newer blood thinner classes work through different pathways and generally don’t interact with vitamin K, but only your prescriber can confirm which type you take. Certain antibiotics and fat-blocking medications can also lower vitamin K status. Always list every supplement at medical appointments.

Can you get too much vitamin K2?

Toxicity from K2 in food or supplements hasn’t been documented in healthy people, which is why U.S. authorities have never set a tolerable upper intake level for vitamin K. Unlike vitamins A and D, K2 is metabolized and cleared relatively quickly rather than accumulating in body fat for long periods. That said, the absence of a known ceiling isn’t an invitation to megadose — trials showing safety used moderate amounts over defined periods, and more hasn’t been shown to be better.

Who should not take vitamin K2?

People taking vitamin K antagonist blood thinners should not take K2 or significantly change their vitamin K intake without their prescriber’s explicit guidance — this is the firmest rule in vitamin K safety. People with kidney disease should involve their care team, since mineral balance is managed differently. Pregnant and breastfeeding women should stick to food sources and prenatal vitamins unless advised otherwise, and anyone with upcoming surgery should disclose K2 use beforehand.

References

• Vitamin K, MedlinePlus, U.S. National Library of Medicine
• Vitamins and minerals — Vitamin K, NHS

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.